BB-14-KA05_0.01uM Gene Set
| Dataset |
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
|
| Category |
transcriptomics
|
| Type |
drug perturbation |
| Description |
Dose=0.01uM, Droxidopa, Norepinephrine Precursors targeting ADRA1D, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 (Novartis, 92974)
|
| External Link |
https://pubchem.ncbi.nlm.nih.gov/compound/92974
|
| Similar Terms |
|
| Downloads & Tools |
|
Genes
8 genes differentially expressed following the BB-14-KA05_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
increased expression
| Symbol |
Name |
Standardized Value |
|
MYL6
|
myosin, light chain 6, alkali, smooth muscle and non-muscle
|
0.824942
|
|
NPC2
|
Niemann-Pick disease, type C2
|
0.70292
|
|
TRAP1
|
TNF receptor-associated protein 1
|
0.70292
|
|
UFD1
|
ubiquitin recognition factor in ER associated degradation 1
|
0.341851
|
|
RPS3
|
ribosomal protein S3
|
0.333726
|
|
IL34
|
interleukin 34
|
0.321363
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
0.261171
|
decreased expression
| Symbol |
Name |
Standardized Value |
|
MED10
|
mediator complex subunit 10
|
-0.240888
|